Skip to main content
. Author manuscript; available in PMC: 2022 Apr 8.
Published in final edited form as: J Hum Lact. 2019 Jan 10;35(2):261–271. doi: 10.1177/0890334418819465

Table 3.

Comparison of the Most Common Adverse Events Between Metformin (Glucophage XR) and Placebo Groups (N = 15).

Adverse events  Metformin
(n = 9)
n (%)
Placebo
(n = 5)
n (%)
Fisher’s Exact Test p
Maternal
 Diarrhea / loose stools 5 (56) 2 (40) .37 1.00
 Nausea/Vomiting 4 (44) 0 (0) .13 .22
 Either of the above symptoms 6 (67) 2 (40) .28 .58
 Abdominal pain/ cramping / bloating 4 (56) 3 (60) .37 1.00
 Headache 3 (33) 0 (0) .23 .26
 Other 2 (22) 4 (80) .06 .09
Infant
 Gastric reflux 3 (33) 0 (0) .23 .26
 Gas 2 (22) 2 (40) .36 .58
 Constipation 1 (11) 1 (20) .49 1.00
 Diarrhea / loose stools 1 (11) 2 (40) .25 .51
 Any of the above symptoms 5 (56) 4 (80) .31 .58
 Insufficient weight gain 1 (11) 0 (0) .64 1.00
 Runny nose / cold symptoms 2 (22) 0 (0) .40 .51
 Irritability 2 (22) 0 (0) .40 .51
 Other 1 (11) 1 (20) .49 1.00

Note. Metformin formulation used in this study was Glucophage XR; n=9 represents only those who took the study drug (the one participant assigned metformin did not take the study drug). Fisher’s Exact Test Table Probability and two-sided p-value.